carbostyril has been researched along with Cytomegalovirus Infections in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cecchetti, V; Gribaudo, G; Loregian, A; Massari, S; Mercorelli, B; Palù, G; Pannecouque, C; Sabatini, S; Sancineto, L; Tabarrini, O | 1 |
| Watanabe, A | 1 |
2 other study(ies) available for carbostyril and Cytomegalovirus Infections
| Article | Year |
|---|---|
Design, synthesis, and evaluation of WC5 analogues as inhibitors of human cytomegalovirus Immediate-Early 2 protein, a promising target for anti-HCMV treatment.
Topics: Aminoquinolines; Antiviral Agents; Cell Line; Cell Survival; Cytomegalovirus; Cytomegalovirus Infections; Drug Design; HEK293 Cells; HIV-1; Humans; Immediate-Early Proteins; Quinolones; Structure-Activity Relationship; Trans-Activators; Virus Replication | 2013 |
[Respiratory tract infections in the elderly, advances and limitations in the diagnosis and treatment].
Topics: Aged; Aminoglycosides; Anti-Bacterial Agents; Cross Infection; Cytomegalovirus Infections; Dibekacin; Erythromycin; Humans; Methicillin Resistance; Pseudomonas aeruginosa; Pseudomonas Infections; Quinolones; Respiratory Tract Infections; Staphylococcal Infections; Vancomycin | 1992 |